SIC
GSK icon

Samalin Investment Counsel’s GSK GSK Stock Holding History

Samalin Investment Counsel’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,954
Closed -$173K – 285
2019
Q4 		$173K Buy
+2,954
New +$164K 0.15% 164

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Samalin Investment Counsel's GSK Position: Q1 2020 in Review

Samalin Investment Counsel sold out of GSK (GSK) in Q1 2020, closing a stake of 2,954 shares — an estimated $173K sold.

Samalin Investment Counsel first reported a position in GSK in Q4 2019 and held it in 1 quarter. The position peaked at $173K in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Samalin Investment Counsel reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Samalin Investment Counsel sold 2,954 GSK shares in Q1 2020, an estimated $173K.
  • Samalin Investment Counsel first reported a position in GSK in Q4 2019 and held it in 1 quarter.
  • Samalin Investment Counsel's GSK position peaked at $173K in Q4 2019.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Samalin Investment Counsel's 13F filing for Q1 2020, filed 4 May 2020.